Heptagon Driehaus US Micro Cap Eq A$ Acc |
Performance History | 31/03/2024 |
Growth of 1,000 (EUR) |
Fund | 69.2 | 32.8 | -29.2 | 8.1 | 17.1 | |
+/-Cat | 52.3 | 6.1 | -11.7 | -5.1 | 8.2 | |
+/-Idx | - | 7.9 | -14.8 | -6.8 | 9.8 | |
Category: US Small-Cap Equity | ||||||
Benchmarks: Morningstar US Sml Ext NR USD |
Key Stats | ||
NAV 23/04/2024 | USD 313.06 | |
Day Change | 2.21% | |
Morningstar Category™ | US Small-Cap Equity | |
ISIN | IE00BDB52V94 | |
Fund Size (Mil) 23/04/2024 | USD 800.92 | |
Share Class Size (Mil) 23/04/2024 | USD 2.91 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/01/2024 | 1.70% |
Investment Objective: Heptagon Driehaus US Micro Cap Eq A$ Acc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Inception Date 12/01/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell Micro Cap Growth TR USD | Morningstar US Sml Ext NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Heptagon Driehaus US Micro Cap Eq A$ Acc | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Modine Manufacturing Co | Consumer Cyclical | 3.10 |
Crinetics Pharmaceuticals Inc | Healthcare | 2.70 |
FTAI Aviation Ltd | Industrials | 2.45 |
Camtek Ltd | Technology | 2.39 |
Xenon Pharmaceuticals Inc | Healthcare | 2.19 |
Increase Decrease New since last portfolio | ||
Heptagon Driehaus US Micro Cap Eq A$ Acc |